The global API market is characterized by its robust growth trajectory, fueled by a combination of aging populations, growing awareness of health issues, and advances in drug development. As pharmaceutical companies continue to emphasize innovation and sustainability, the demand for high-quality APIs is at an all-time high. Moreover, the COVID-19 pandemic has amplified the need for a secure and reliable supply chain for APIs, underscoring their critical role in drug production.